Giuliani, Giovanni; Chassagnol, Frederic; Traub, David; … - In: Health Economics Review 8 (2018) 24, pp. 1-11
. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as … medicines was 63 (Germany), 459 (Italy), and 557 days (France). Conclusions: The clinical domains of the EUnetHTA framework are …